Atlas Trials

Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects

Clinical trial NCT00320307 · COMPLETED

Trial details

NCT number
NCT00320307
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infection
Start date
2005-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.